This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hibercell, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Fredrik Rahm in Cancer Treatment
Introduction
Fredrik Rahm is an accomplished inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases.
Latest Patents
Fredrik holds a patent for "Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors." This invention relates to inhibitors of PI5P4K, which are useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases. His work in this area is crucial for advancing therapeutic options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Fredrik Rahm has established himself as a key figure in the pharmaceutical industry. His role at Hibercell, Inc. has allowed him to focus on groundbreaking research and development. His expertise in medicinal chemistry and pharmacology has been instrumental in driving forward innovative solutions in healthcare.
Collaborations
Fredrik has collaborated with notable colleagues, including Johan Lindström and Lars Boukharta Persson. These partnerships have fostered a collaborative environment that enhances the potential for impactful discoveries.
Conclusion
Fredrik Rahm's contributions to the field of medical research exemplify the importance of innovation in developing new treatments for serious health conditions. His work continues to inspire advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile